Atracurium Besylate

• CAT Number: A000487
• CAS Number: 64228-81-5
• Molecular Formula: C65H82N2O18S2
• Molecular Weight: 1243.5
• Purity: ≥95%
• Synonyms: Atracurium besilate; 64228-81-5; Tracrium; Atracurii besilas; Besilate d/’atracurium
• Storage: -20°C
• IUPAC Name: benzenesulfonate;5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
• InChI: InChI=1S/C53H72N2O12.C6H6O3S/c1-12-13-14-27-66-50(56)21-25-55(3)24-20-38-40(42(55)29-36-16-18-44(59-5)46(31-36)61-7)34-49(64-10)53(65-11)52(38)67-51(57)22-26-54(2)23-19-37-32-47(62-8)48(63-9)33-39(37)41(54)28-35-15-17-43(58-4)45(30-35)60-6;7-10(8,9)6-4-2-
• InChIKey: XXZSQOVSEBAPGS-UHFFFAOYSA-L
• SMILES: C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]

Atracurium Besilate (CAS 64228-81-5) is a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Atracurium is classified as an intermediate-duration non-depolarizing neuromuscular-blocking agent.

Reference

1: Spina R, Voss DM, Asnaghi L, Sloan A, Bar EE. Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells. Oncotarget. 2016 Jan 5;7(1):459-72. doi: 10.18632/oncotarget.6314. PubMed PMID: 26575950; PubMed Central PMCID: PMC4808011.
2: Galluzzi F, De Rensis F, Saleri R, Spattini G. Effect of urethral infusion of atracurium besylate on manual bladder expression in dogs and cats with spinal cord injuries: a randomised trial. Vet Rec. 2015 May 23;176(21):545. doi: 10.1136/vr.102825. Epub 2015 Apr 28. PubMed PMID: 25920417.
3: Galluzzi F, De Rensis F, Menozzi A, Spattini G. Effect of intraurethral administration of atracurium besylate in male cats with urethral plugs. J Small Anim Pract. 2012 Jul;53(7):411-5. doi: 10.1111/j.1748-5827.2012.01239.x. PubMed PMID: 22747734.
4: de Moraes Mde L, Polakiewicz B, Mattua MF, Tavares MF. Comparative evaluation of capillary electrophoresis and high-performance liquid chromatography for the separation of cis-cis, cis-trans, and trans-trans isomers of atracurium besylate. J Capillary Electrophor. 1998 Jan-Apr;5(1-2):33-8. PubMed PMID: 10327367.
5: Smith CE, van Miert MM, Parker CJ, Hunter JM. A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1/'R-cis isomer of atracurium, with atracurium besylate in healthy patients. Anaesthesia. 1997 Sep;52(9):833-41. PubMed PMID: 9349062.
6: Bhatt-Mehta V, Hirata S. Physical compatibility and chemical stability of atracurium besylate and midazolam hydrochloride during intravenous coinfusion. Int J Pharm Compd. 1998 Jan-Feb;2(1):79-82. PubMed PMID: 23989485.
7: Bovianska N. [The use of atracurium besylate (Tracrium) in patients undergoing kidney transplantation]. Khirurgiia (Sofiia). 1997;50(1):60-2. Bulgarian. PubMed PMID: 9379624.
8: Pramar YV, Loucas VA, Word D. Chemical stability and adsorption of atracurium besylate injections in disposable plastic syringes. J Clin Pharm Ther. 1996 Jun;21(3):173-5. PubMed PMID: 8873851.
9: Eastwood NB, Boyd AH, Parker CJ, Hunter JM. Pharmacokinetics of 1R-cis 1/'R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure. Br J Anaesth. 1995 Oct;75(4):431-5. PubMed PMID: 7488483.
10: Shorten GD, Gibbs NM. Dose-response relationship of atracurium besylate in the halothane-anaesthetised pig. Res Vet Sci. 1993 Nov;55(3):392-3. PubMed PMID: 8284509.